Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Azienda Ospedaliero Universitaria di Sassari clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Italy register with Azienda Ospedaliero Universitaria di Sassari as lead sponsor. Synced 17 Nov 2026
3Current trials
1Recruiting now
0Drugs in these trials
1Trial register
At a glance

Azienda Ospedaliero Universitaria di Sassari is the lead sponsor of 3 current clinical trials in our Italy register. 1 is recruiting patients now. The most common phase is Not applicable. The most-studied condition is Left Bundle Branch Block (LBBB) on ECG.

ClinicalTrials.gov trials by status

  • Recruiting133%
  • Not yet open267%

Trials by phase

  • Not applicable267%
  • Observational133%
01

Clinical trials sponsored by Azienda Ospedaliero Universitaria di Sassari

3 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Clinical Observational Registry of Patients With Left Bundle Branch Block
NCT05283603 · ClinicalTrials.gov ↗ · Left Bundle Branch Block (LBBB) on ECG
Observational Recruiting 2019-07 Italy
Virtual Reality-Based Cardiac Rehabilitation in Patients Undergoing Cardiac Surgery
NCT07782749 · ClinicalTrials.gov ↗ · Cardiac Rehabilitation
Not applicable Not yet open 2026-09 Italy
Music Medicine in Coronary Interventional Cardiology Procedures
NCT07786961 · ClinicalTrials.gov ↗ · Acute Coronary Syndrome
Not applicable Not yet open 2026-09 Italy

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Azienda Ospedaliero Universitaria di Sassari trials

3 conditions
Left Bundle Branch Block (LBBB) on ECG1Cardiac Rehabilitation1Acute Coronary Syndrome1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Italy31

A trial with sites in more than one country appears in each of those registers.

04

Questions about Azienda Ospedaliero Universitaria di Sassari trials

How many clinical trials does Azienda Ospedaliero Universitaria di Sassari sponsor?

Azienda Ospedaliero Universitaria di Sassari is the lead sponsor of 3 current trials on ClinicalTrials.gov in our Italy register, as of the registry sync on 17 November 2026. Completed and withdrawn studies are not counted.

Are Azienda Ospedaliero Universitaria di Sassari trials recruiting?

Yes. 1 of its 3 ClinicalTrials.gov trials is recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 17 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.